133 related articles for article (PubMed ID: 25065557)
1. Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
Nadir Y; Sarig G; Axelman E; Meir A; Wollner M; Shafat I; Hoffman R; Brenner B; Vlodavsky I; Haim N
Thromb Res; 2014 Sep; 134(3):639-42. PubMed ID: 25065557
[TBL] [Abstract][Full Text] [Related]
2. An assay to evaluate heparanase procoagulant activity.
Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
[TBL] [Abstract][Full Text] [Related]
3. Heparanase procoagulant activity is elevated in women using oral contraceptives.
Matan M; Axelman E; Brenner B; Nadir Y
Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
[TBL] [Abstract][Full Text] [Related]
4. Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.
Peled E; Rovitsky A; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2012 Jul; 130(1):129-34. PubMed ID: 22154361
[TBL] [Abstract][Full Text] [Related]
5. Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses.
Nadir Y; Saharov G; Hoffman R; Keren-Politansky A; Tzoran I; Brenner B; Shochat T
Ann Hematol; 2015 Jul; 94(7):1213-9. PubMed ID: 25743687
[TBL] [Abstract][Full Text] [Related]
6. Heparanase level and procoagulant activity are reduced in severe sepsis.
Matan M; King D; Peled E; Ackerman S; Bar-Lavi Y; Brenner B; Nadir Y
Eur J Haematol; 2018 Feb; 100(2):182-188. PubMed ID: 29120525
[TBL] [Abstract][Full Text] [Related]
7. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
8. Heparanase procoagulant activity.
Nadir Y; Brenner B
Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of heparanase activity in primary resected non-small cell lung cancer.
Takahashi H; Ebihara S; Okazaki T; Suzuki S; Asada M; Kubo H; Sasaki H
Lung Cancer; 2004 Aug; 45(2):207-14. PubMed ID: 15246192
[TBL] [Abstract][Full Text] [Related]
10. Novel peptides that inhibit heparanase activation of the coagulation system.
Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
[TBL] [Abstract][Full Text] [Related]
11. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
12. Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.
Peled E; Melamed E; Portal TB; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2016 Mar; 139():148-53. PubMed ID: 26916313
[TBL] [Abstract][Full Text] [Related]
13. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.
Regina S; Valentin JB; Lachot S; Lemarié E; Rollin J; Gruel Y
Clin Chem; 2009 Oct; 55(10):1834-42. PubMed ID: 19661141
[TBL] [Abstract][Full Text] [Related]
14. Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.
Crispel Y; Axelman E; Tatour M; Kogan I; Nevo N; Brenner B; Nadir Y
Thromb Haemost; 2016 Sep; 116(4):669-78. PubMed ID: 27535490
[TBL] [Abstract][Full Text] [Related]
15. Heparanase Level and Procoagulant Activity Are Increased in Thalassemia and Attenuated by Janus Kinase 2 Inhibition.
Ghoti H; Ackerman S; Rivella S; Casu C; Nadir Y
Am J Pathol; 2020 Oct; 190(10):2146-2154. PubMed ID: 32745462
[TBL] [Abstract][Full Text] [Related]
16. Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor.
Treger S; Ackerman S; Kaplan V; Ghanem S; Nadir Y
Hum Reprod; 2021 Jan; 36(1):61-69. PubMed ID: 33306105
[TBL] [Abstract][Full Text] [Related]
17. Heparanase in the Coagulation System.
Nadir Y
Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Crispel Y; Ghanem S; Attias J; Kogan I; Brenner B; Nadir Y
J Thromb Haemost; 2017 Jul; 15(7):1463-1472. PubMed ID: 28439967
[TBL] [Abstract][Full Text] [Related]
19. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
20. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
